Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function

被引:28
作者
Moosgaard, B.
Vestergaard, P.
Heickendorff, L.
Mosekilde, L.
机构
[1] Aarhus Univ Hosp, Dept Endocrinol & Metab C, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Clin Chem, DK-8000 Aarhus C, Denmark
关键词
D O I
10.1111/j.1365-2265.2006.02680.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Primary hyperparathyroidism (PHPT) is characterized by elevated plasma levels of PTH and calcium with reduced plasma phosphate. Physiologically, renal 1 alpha,25-dihydroxyvitamin D [1,25(OH)(2)D] production is stimulated by PTH and phosphate deprivation, and inhibited by 1,25(OH)(2)D itself and calcium. Aim To investigate relations between circulating levels of 1,25(OH)(2)D, 25-dihydroxyvitamin D (25OHD), PTH, calcium, phosphate, renal function and skeletal complications in patients with PHPT. Design Cross-sectional study. Material Two hundred and fifty-two consecutive hypercalcaemic Caucasian patients aged 24-91 (median 65.9) years (85.3% females) with PHPT. Results In patients with PHPT, plasma 1,25(OH)(2)D was increased by 27% [107 (9-250) pmol/l, median (range)] compared to controls [84 (18-172) pmol/l, P < 0.001]. In univariate models, plasma 1,25(OH)(2)D depended inversely on age (r = -0.23, P < 0.001) and plasma phosphate (r = -0.23, P < 0.001) and positively on plasma calcium (r = 0.14, P < 0.05), plasma 25OHD (r = 0,15, P < 0.05) and creatinine clearance rate (r = 0.32, P < 0.001). In the final multiple regression model, plasma 1,25(OH)(2)D depended positively on renal function (r(p) = 0.43, P < 0.001) and female sex (r(p) = 0.15, P < 0.05) but inversely on body mass index (BMI; r(p) = -0.23, P < 0.005) and plasma phosphate (r(p) = -0.18, P < 0.05). Plasma 1,25(OH)(2)D correlated positively with renal calcium excretion and inversely with lumbar spine bone mineral density (BMD) but was not associated with risk of fractures or renal stones. Conclusion Patients with PHPT have elevated plasma 1,25(OH)(2)D levels but, to a large extent, individual values overlap controls. The increase in plasma 1,25(OH)(2)D depends on renal function, hypophosphataemia and the female sex and is attenuated by high BMI. High plasma 1,25(OH)(2)D is associated with higher plasma calcium levels.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 53 条
[1]   EFFECTS OF ORAL CACO3 LOADING AND DIETARY CALCIUM DEPRIVATION ON PLASMA 1,25-DIHYDROXYVITAMIN-D CONCENTRATIONS IN HEALTHY-ADULTS [J].
ADAMS, ND ;
GRAY, RW ;
LEMANN, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (06) :1008-1016
[2]   Body fat content and 25-hydroxyvitamin D levels in healthy women [J].
Arunabh, S ;
Pollack, S ;
Yeh, J ;
Aloia, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :157-161
[3]   Clinical practice - Asymptomatic primary hyperparathyroidism [J].
Bilezikian, JP ;
Silverberg, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (17) :1746-1751
[4]  
BILEZIKIAN JP, 1991, J BONE MINER RES S2, V6, P85
[5]   Association between primary hyperparathyroidism and increased body weight: A meta-analysis [J].
Bolland, MJ ;
Grey, AB ;
Gamble, GD ;
Reid, IR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1525-1530
[6]   A DETAILED EVALUATION OF ORAL PHOSPHATE THERAPY IN SELECTED PATIENTS WITH PRIMARY HYPERPARATHYROIDISM [J].
BROADUS, AE ;
MAGEE, JS ;
MALLETTE, LE ;
HORST, RL ;
LANG, R ;
JENSEN, PS ;
GERTNER, JM ;
BARON, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (05) :953-961
[7]   IMPORTANCE OF CIRCULATING 1,25-DIHYDROXYVITAMIN-D IN THE PATHOGENESIS OF HYPERCALCIURIA AND RENAL-STONE FORMATION IN PRIMARY HYPERPARATHYROIDISM [J].
BROADUS, AE ;
HORST, RL ;
LANG, R ;
LITTLEDIKE, ET ;
RASMUSSEN, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (08) :421-426
[8]   PRIMARY HYPERPARATHYROIDISM - EVALUATED BY CA-47 KINETICS, CALCIUM BALANCE AND SERUM BONE-GLA-PROTEIN [J].
CHARLES, P ;
MOSEKILDE, L ;
JENSEN, ET .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1986, 16 (04) :277-283
[9]   FEEDBACK REGULATION OF VITAMIN-D METABOLISM BY 1,25-DIHYDROXYCHOLECALCIFEROL [J].
COLSTON, KW ;
EVANS, IMA ;
SPELSBERG, TC ;
MACINTYRE, I .
BIOCHEMICAL JOURNAL, 1977, 164 (01) :83-89
[10]   REGULATION OF 25-HYDROXYCHOLECALCIFEROL-1-HYDROXYLASE ACTIVITY IN KIDNEY BY PARATHYROID-HORMONE [J].
FRASER, DR ;
KODICEK, E .
NATURE-NEW BIOLOGY, 1973, 241 (110) :163-166